3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Thoracic
1
Sarcoma
1
Other hematologic neoplasm
1
Head & Neck
1
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumors
1
Sarcoma
1
Liposarcoma
1
Histiocytoma, Malignant Fibrous
1
Dermatofibrosarcoma
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
30
pembrolizumab
24
Magnetic Resonance Spectroscopy
24
Specimen Handling
20
Cetuximab
18
Nivolumab
15
Carboplatin
14
Platinum
12
1,2-diaminocyclohexaneplatinum II citrate
12
Radiotherapy, Intensity-Modulated
11
Radiotherapy
10
Radiation
9
Paclitaxel
9
Docetaxel
8
Biopsy
8
Immunoglobulin G
7
Disulfides
7
Surveys and Questionnaires
6
Ipilimumab
6
atezolizumab
5
Fluorouracil
5
toripalimab
4
dostarlimab
4
cemiplimab
4
cabozantinib
4
Taxes
4
Gemcitabine
4
CTLA-4 Antigen
4
Bevacizumab
4
(225)Ac-DOTA-c(RGDyK)
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Famotidine
×
Head & Neck
×
30 days
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled